Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Actavis targets schizophrenia and bipolar disorder with launch

Manufacturer Actavis has launched a product to help treat symptoms of mental illness.

 

Aripiprazole, which launched last month, can be used to treat schizophrenia in patients aged over 15, as well as moderate and severe manic episodes of bipolar disorder, Actavis said.

 

The tablets are available in both conventional and orodispersible forms. Packs of 28 conventional tablets in strengths of 5mg, 10mg and 15mg are priced at £76.83, while a pack of 28 30mg tablets is £153.66. Packs of 28 10mg and 15mg orodispersible tablets both come at £96.04.

 

Actavis UK managing director Jonathan Wilson said expanding the company’s portfolio would “better cover pharmacists’ needs and save them both time and costs”.


To order, contact the Actavis telemarketing team on 0800 731 0370

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD017589

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel